LYON, France--(BUSINESS WIRE)--POXEL S.A. (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today that it will be featured as a presenting company at the Jefferies 2019 Global Healthcare Conference and the JMP Securities Life Sciences Conference. In addition, Imeglimin will be discussed during a symposium at the 62nd Annual Meeti
SAN FRANCISCO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/EHA24?src=hash" target="_blank"gt;#EHA24lt;/agt;--Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced that an abstract describing clinical data regarding their lysine-specific demethylase (LSD1) inhibitor has been selected for an oral presentation at the 24th Congress of the European Hematology Association (EHA) to be held in Amsterdam, The Netherlands from June 13-16, 2019. The abstract was published on the EHA website. Title: A
SAN LEANDRO, Calif.--(BUSINESS WIRE)--Rainier Therapeutics, Inc., a privately-held clinical stage drug development company, today announced the presentation of data from its FIERCE-22 trial where vofatamab, the company’s lead therapeutic stimulates an increase in immune cell activation in patients with metastatic bladder cancer. The data is being presented in an oral and poster presentation at the 2019 American Association for Cancer Research (AACR) Bladder Cancer: Transforming the Field Specia
KENILWORTH, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24MRK&src=ctag" target="_blank"gt;$MRKlt;/agt; lt;a href="https://twitter.com/hashtag/MRK?src=hash" target="_blank"gt;#MRKlt;/agt;--Merck Provides Update on Phase 3 KEYNOTE-119 Study of KEYTRUDA® Monotherapy in Previously-Treated Patients w/ Metastatic Triple-Negative Breast Cancer
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) today announced that Dr. Mohammad Ansari will present DABRA as a treatment for critical limb ischemia (CLI) during a scientific case review May 21 at the SCAI annual meeting in Las Vegas. “The unique DABRA catheter and laser system is a highly effective frontline therapy for peripheral artery disease (PAD) that provides my patients excellent results, shorter rehabilitation time, and shorter hospitalizations,” said Dr. Ansa
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS Medical”) today announced that Executive Chairman Dan Goldberger is scheduled to present at the 9th Annual LD Micro Invitational on June 5, 2019. The event is being held at the Luxe Sunset Hotel in Bel-Air, California. RMS Medical’s presentation will take place at 10:20 am Pacific Time. A copy of the slides will be available under the Investor Relations section of RMS Medical’s website: www.rmsm
BOULDER, Colo.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24CLVS&src=ctag" target="_blank"gt;$CLVSlt;/agt;--Clovis Oncology, Inc. (NASDAQ: CLVS) today announced data demonstrating that patients with recurrent ovarian cancer who received Rubraca in the Phase 3 ARIEL3 study had longer periods of quality-adjusted time without clinically relevant symptoms as compared to patients who received placebo, and that Rubraca maintenance treatment continued to provide significant benefit in progression-free survival when weighted with patients’ perceptions of their wellbeing. The
BEDFORD, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target="_blank"gt;#OCUTXlt;/agt;--Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced topline results from the first pivotal Phase 3 clinical trial of OTX-TP, an intracanalicular insert that delivers a preservative-free formulation of the drug travoprost for the reduction of intraocular pressure (IOP) in patients with primary open-angle
LEHI, Utah--(BUSINESS WIRE)--Frelii Inc. Filed its quarterly report on form 10-Q
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Black & Veatch today hosted the 23rd edition of its Charity Golf Tournament in support of Children’s Mercy. Proceeds from the tournament and company giving totaling $350,000 were donated to the renowned children’s hospital, part of a five-year pledge of $2.1 million made in 2015 to help expand services at the hospital’s Center for Pediatric Genomic Medicine. The annual golf event and company donations have now surpassed $4.1 million since its inception.
GARLAND, Texas--(BUSINESS WIRE)--Galt Medical, a supplier of access products for interventional procedures, acquired Arrotek, a developer of catheter-based interventional devices.
COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has for years successfully demonstrated brain-computer interface (BCI) projects—just look at NeuroLife®, which has enabled a quadriplegic man to move his hand again using his thoughts. Now, the government’s forward-thinking Defense Advanced Research Projects Agency (DARPA) has awarded a contract to a Battelle-led team that pushes researchers into the realm of what was once considered science fiction. Imagine this: A soldier puts on a helmet and uses his
WASHINGTON--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/BIOWC19?src=hash" target="_blank"gt;#BIOWC19lt;/agt;--BIO today announced that Tom Vilsack will receive the 12th annual George Washington Carver Award for Innovation in Industrial Biotechnology.
SAN DIEGO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/guthealth?src=hash" target="_blank"gt;#guthealthlt;/agt;--Gemelli Biotech, in partnership with the Medically Associated Science and Technology (MAST) program at Cedars-Sinai, announced new findings that validate a second-generation diagnostic blood test for irritable bowel syndrome (IBS) as the most accurate ever. Available commercially as ibs-smart™, the test could provide physicians with the most conclusive data currently attainable for ruling in IBS. Primarily applicable to patients with a diarrheal component to their sy
MINNEAPOLIS--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24DCI&src=ctag" target="_blank"gt;$DCIlt;/agt; lt;a href="https://twitter.com/hashtag/earnings?src=hash" target="_blank"gt;#earningslt;/agt;--Donaldson breaks ground on new $15 million R&D facility at its global headquarters in Bloomington, MN.
WASHINGTON--(BUSINESS WIRE)--On May 17th, Texas Governor Greg Abbott signed into law an age-18 requirement for the purchase of over-the-counter (OTC) medicines containing the cough suppressant dextromethorphan (DXM), an ingredient which is abused by some teenagers to get high. Texas is the 19th state to prohibit the sale of OTC cough medicine to minors, joining other large states, including California, New York, and Florida. “For over a decade, OTC manufacturers have worked alongside anti-subst
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences announced the presentation of expanded, long-term data from its Phase 1a/1b study of VE303, its lead product.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, today announced it will present positive full clinical results from the Company’s REDUCE (“Reliable Endoscopic Diagnosis Utilizing Cleansing Enhancement”) study evaluating the Pure-Vu® System at Digestive Disease Week® 2019 (“DDW”). Vladimir Kushnir, M.D., Division of
BOSTON--(BUSINESS WIRE)--The U.S. District Court ruled in favor of Foley Hoag LLP’s client, Dana-Farber Cancer Institute, that Dana-Farber scientist, Gordon Freeman, PhD, and another scientist, Clive Wood, PhD, are co-inventors on a series of cancer immunotherapy patents previously issued to a Japanese researcher and Japanese drug company. The ruling directs that the patents be corrected to name Freeman and Wood as inventors. In her decision, Chief Judge Patti B. Saris wrote that “Dana-Farber h
CRANBURY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Breast?src=hash" target="_blank"gt;#Breastlt;/agt;--Physicians’ Education Resource® to Host ASCO Direct™ Highlights in Kansas City
SAN DIEGO & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens Presents Research Studies at May 2019 Digestive Disease Week: Highlights Value of Non-Invasive Screening for Fatty Liver Disease
REHOVOT, Israel & WILMINGTON, Del.---(BUSINESS WIRE)--Ayala Pharmaceuticals, Inc., a clinical-stage company developing medicines for cancers that are genetically defined, today announced updates on AL101, a pan-Notch inhibitor, that will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Il. The details of the poster presentations are as follows: Title: ACCURACY: phase (P) 2 trial of AL101, a pan-Notch inhibitor, in patients (pts) with recurrent/met
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/INDstatus?src=hash" target="_blank"gt;#INDstatuslt;/agt;--PharmaCyte proceeding with GMP production of pancreatic cancer product after successful changes to manufacturing process.
TEL AVIV, Israel & LEHI, Utah--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/dna?src=hash" target="_blank"gt;#dnalt;/agt;--MyHeritage Expands to Health; Launches New DNA Test Offering Powerful and Personalized Health Insights for Consumers.
OLATHE, Kan.--(BUSINESS WIRE)--NIC Inc. has been selected to provide its RxGov prescription drug monitoring platform to the State of Nebraska.
NEWTON, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/NTI2019?src=hash" target="_blank"gt;#NTI2019lt;/agt;--Cheetah Medical showcases fluid management education with Virtual Trainer app at the 2019 National Teaching Institute & Critical Care Exposition
GERMANTOWN, Md.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/hurricane?src=hash" target="_blank"gt;#hurricanelt;/agt;--Earth Networks released its 2019 Atlantic Hurricane Season Outlook.
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Ltd., announced today that secondary endpoint data from the pivotal Phase III study for HP-3070 (asenapine) transdermal drug delivery system (TDDS), an investigational product for the treatment of schizophrenia, will be featured as a poster presentation at the American Psychiatric Association (APA) 172nd Annual Meeting in San Francisco, May 18 – 22, 2019. This post
MENLO PARK, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/RAPIDai?src=hash" target="_blank"gt;#RAPIDailt;/agt;--iSchemaView, the worldwide leader in advanced imaging for stroke, has launched RAPID U, a training certification program for the RAPID platform.
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to patients through their health care providers. Genomind Professional PGx provides personalized analytics on patient-specific genetic markers. This information helps indicate which medications or other treatment options, for more than 11 mental health conditions, are better suited for a patient based on
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies. With the addition of Paragon’s specialized expertise in adeno-associated virus (AAV) vectors, the most commonly used vect
PARSIPPANY, N.J.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24ZTS&src=ctag" target="_blank"gt;$ZTSlt;/agt; lt;a href="https://twitter.com/hashtag/animalhealth?src=hash" target="_blank"gt;#animalhealthlt;/agt;--Zoetis Inc. will present at the Stifel 2019 Dental & Veterinary Conference on May 29 at 10:30 am ET.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/bioinformatics?src=hash" target="_blank"gt;#bioinformaticslt;/agt;--DNAnexus Appoints David Fenstermacher as Vice President of Precision Medicine and Data Sciences
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
MENLO PARK, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/IOCombos360?src=hash" target="_blank"gt;#IOCombos360lt;/agt;--Personalis Enters into a Research Agreement with FLX Bio to Provide Comprehensive Tumor Immunogenomic Profiling for Clinical Study.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/bioinformatics?src=hash" target="_blank"gt;#bioinformaticslt;/agt;--DNAnexus Appoints Scott Gibson as Chief Financial Officer
SAN FRANCISCO--(BUSINESS WIRE)--Savonix to Present at Upcoming Industry & Scientific Conferences
SUNNYVALE, Calif.--(BUSINESS WIRE)--Druva, Inc., the leader in cloud data protection and management, today announced the National Cancer Institute (NCI), the federal government's primary agency addressing cancer research and treatment, is using Druva to replace its legacy hardware solutions for backup, restore and archiving of data. As the only FedRAMP certified data management solution, Druva’s unique technology ensures compliance with stringent government regulations and ease of management wi
WILMINGTON, Del.--(BUSINESS WIRE)--A new integrated analysis of Phase III data for FASENRA® (benralizumab) shows that patients with severe eosinophilic asthma who were continuously treated with the medicine for up to two years reduced their use of oral corticosteroids (OCS) and experienced a sustained improvement in exacerbation rates, lung function, asthma control and health-related quality of life. The analysis, presented today at the American Thoracic Society (ATS) 2019 International Confere
ARLINGTON, Va.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/EHR?src=hash" target="_blank"gt;#EHRlt;/agt;--Expanded award eligibility and updated criteria elevate industry leaders who make meaningful changes to enhance patient safety and healthcare delivery
CAMPBELL, Calif.--(BUSINESS WIRE)--Saama challenges analytics industry to guarantee data platforms to accelerate drug development; Saama Guarantee leads this call-to-action.
TAMPA, Fla.--(BUSINESS WIRE)--Phase 2 Clinical Trial Enrollment Progresses While World Health Organization Provides Generic Name of AG013 Compound
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announces that data from key studies within its inflammation and autoimmunity portfolio will be presented at the 24th World Congress of Dermatology (WCD). This meeting will be held in Milan, Italy from June 10-15, 2019. Presentations will feature 24-week data from a Phase 2 study of ruxolitinib cream in adult patients with vitiligo, which will be highlighted during the late-breaking research session, and 12-week data from a Pha
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24KALV&src=ctag" target="_blank"gt;$KALVlt;/agt;--KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, announced that data has been accepted for presentation at both the C1 Inhibitor Deficiency and Angioedema Workshop in Budapest, Hungary and European Academy of Allergy and Clinical Immunology (EAACI) Congress in Lisbon, Portugal. “We are excited to present
ANN ARBOR, Mich.--(BUSINESS WIRE)--lt;a href="https://twitter.com/search?q=%24KBLB&src=ctag" target="_blank"gt;$KBLBlt;/agt; lt;a href="https://twitter.com/hashtag/KBLB?src=hash" target="_blank"gt;#KBLBlt;/agt;--Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that its subsidiary Prodigy Textiles has taken possession of its factory in Vietnam. The Company is now retrofitting the nearly 50,000 square foot facility to produce its game changing recombinant spider silk materials. Remodeling efforts are expected to be minimal and completed quickly. This facility was selected based on its optimal
REDWOOD SHORES, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/AUA19?src=hash" target="_blank"gt;#AUA19lt;/agt;--New clinical data presented at AUA 2019 position PROCEPT BioRobotics' Aquablation therapy as new standard of care for patients suffering from BPH.
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite’s Phase II Liver Cancer Data Selected for Presentation at a Leading Liver Cancer Scientific Forum (ILCA)
WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the schedule of key presentations to be featured during a lunch symposium at the 2019 New Cardiovascular Horizons (NCVH) Conference, May 29th through 31st at The Roosevelt New Orleans in New Orleans, Louisiana. Recently FDA-approved for above-the-knee interventions, the Tack Endovascular System is a first-of-its-kind dissection repair device i
WALTHAM, Mass.--(BUSINESS WIRE)--Clinique Pasteur is first European site to adopt latest CorPath GRX vascular robotic technology; Corindus to showcase technology at EuroPCR 2019
STAMFORD, Conn.--(BUSINESS WIRE)--SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat in Adult Patients with Desmoid Tumors
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Magellan Rx Management released its second Employer Market Insights Report, which highlights key areas of pharmacy trend and spend.
MEMPHIS, Tenn.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/Cancer?src=hash" target="_blank"gt;#Cancerlt;/agt;--Inteliquet has entered into a Cooperative Research and Development Agreement with NCI.
MENLO PARK, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/immuno19?src=hash" target="_blank"gt;#immuno19lt;/agt;--Personalis, Inc. to Present at Advances in Immuno-Oncology Congress UK 2019: Advancing Precision Oncology Biomarker Discovery with ImmunoID NeXT.
NEUCHATEL, Switzerland--(BUSINESS WIRE)--A new study evaluates the ability of Masimo SpHb® (noninvasive hemoglobin) to help clinicians estimate when to conduct invasive measurement.